<DOC>
	<DOC>NCT00482196</DOC>
	<brief_summary>To study different doses of MK0493 for safety, efficacy and tolerability in obese patients.</brief_summary>
	<brief_title>To Study Different Levels of MK0493 for Safety, Efficacy, and Tolerability in Obese Patients (0493-017)(COMPLETED)</brief_title>
	<detailed_description />
	<criteria>Patient is between 21 and 65 years of age HIV positive as determined by medical history Patient is pregnant, lactating or plans to become pregnant Patient has undergone surgical treatment for obesity Patient has undergone a surgical procedure within 4 weeks prior to Visit 1 or plans to undergo a surgical procedure during the study Patient plans to consume more than 2 glasses of grapefruit juice per day during the study Patient has participated in another clinical study (involving an investigational drug) within 3 months prior to restudy screening</criteria>
	<gender>All</gender>
	<minimum_age>21 Years</minimum_age>
	<maximum_age>65 Years</maximum_age>
	<verification_date>April 2015</verification_date>
</DOC>